Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 70594-053

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 70594-053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xellia Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Daptomycin 01)

Chemical structure diagram of Daptomycin showing its molecular arrangement with multiple amino acid residues and functional groups characteristic of this complex lipopeptide antibiotic.*

FDA Label Image

Principal Display Panel (350 mg Vial Carton)

Packaging label for Daptomycin for Injection, 350 mg/vial, lyophilized powder for intravenous injection. The label includes storage instructions indicating the product must be refrigerated between 2°C and 8°C. It also states to use 0.9% Sodium Chloride Injection for reconstitution. The product is manufactured by Xellia Pharmaceuticals USA LLC, with the NDC 70594-053-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.